ClinicalTrials.gg
Not yet recruitingNCT07760298IBSUpdated Aug 12, 2026

Calisthenics Versus Cycling Exercises on Interleukin-6 and Quality of Life in Benha University Students With Irritable Bowel Syndrome

An interventional study of Calisthenics exercises and Cycling Exercises in Irritable Bowel Syndrome, sponsored by Cairo University. Not yet recruiting. Open to female participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 12 studies in Irritable Bowel Syndrome by Cairo University — 8 open to participants now, 8 under way, none of them phase 3. Irritable Bowel Syndrome · Cairo University.

Planned enrollment
3rd of 11
60 · median 60
Started
2026
with 2 others
No phase
11 of 12
7 open now
Registered
12th of 12
by date

Among the 12 studies in Irritable Bowel Syndrome by Cairo University, this one is the 3rd largest by planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2026, is one of 11 with no phase, and was the 12th registered.

Irritable Bowel Syndrome

1,116 studies on the registry are indexed under Irritable Bowel Syndrome; 208 are open to participants now.

Browse Irritable Bowel Syndrome studies →

Open to participants now

8 of the 12 studies in Irritable Bowel Syndrome by Cairo University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 126 Irritable Bowel Syndrome studies recruiting now, 33 (26%) set no upper age limit and 83 (66%) stop at 75 or younger; 18 take children under 18; 28 take healthy volunteers.

This study: 18 Years to 25 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Irritable Bowel Syndrome by Cairo University, or all of them as a file.
02

Study summary

this study will be conducted to compare between the effect of calisthenics versus cycling exercises on interleukin-6 and quality of life in Benha University students with irritable bowel syndrome.

Read the detailed description

Irritable bowel syndrome (IBS) is one of the most common chronic gastro-intestinal disorders affecting up to 20 % of the population all over the world and affecting approximately 9-22% of the European adult population and affecting female more than male.Irritable bowel syndrome (IBS) is one of the most common functional bowel disorders, and has substantial implications for the lives of patients, as well as a huge economic impact on society. The high prevalence of Irritable bowel syndrome (IBS) is associated with a marked reduction in health-related quality of life, higher rates of somatisation, increased likelihood of psychological comorbidity, including depression and suicidal ideation, and work impairment, as well as greater medical and prescription medicine costs per year .Students, especially those who are undergraduates, are highly liable to IBS that is linked to increased stresses as exams and because they always rely on fast foods for their diet. Similarly, dietary pattern has significant negative effect on IBS. IBS can affect the academic performance of the studying students.Physical exercises help people with IBS by increasing the motility of the stomach and encouraging regular bowel movements, lowering stress and anxiety by releasing endorphins, and strengthening the gut microbiota to reduce inflammation and improve barrier function. Additionally, using bodyweight activities can help people with IBS improve their overall quality of life by reducing bloating and improving gas evacuation

03

Conditions studied

  • Irritable Bowel Syndrome

Keywords

  • Calisthenics
  • Cycling Exercises
  • Interleukin-6
  • Quality of Life
  • Benha University Students With Irritable Bowel Syndrome
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • females will be aged from 18 to 25 years old
  • diagnosis by Rome IV diagnostic criteria
  • will be 18.5- 29.5 kg\m2
  • (Moderate-severe) severity of IBS.

Exclusion criteria

Exclusion Criteria:

  • organic gastro -intestinal disorders
  • thyroid dysfunctions
  • concurrent cardio vascular?
  • respiratory, renal, hepatic disorders
  • neurological/musculoskeletal problems,
  • psychiatric disease,
  • hematological disease,
  • previous history of stomach or intestinal excision.
  • will be >30 kg\m2
  • Participating in any other ex progrm
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Calisthenics exercises

    Twenty patients with IBS will be trained by calisthenics exercises, 3 times per week for 2 months with diet advices.

    Other: Calisthenics exercises · Other: diet advices

  • Experimental
    Cycling Exercises

    Twenty patients with IBS will be trained by cycling exercises, 3 times per week for 2 months, with diet advices.

    Other: Cycling Exercises · Other: diet advices

  • Active comparator
    diet advices

    Twenty patients with IBS will diet advices for 2 months

    Other: diet advices

Interventions

  • OtherCalisthenics exercises

    The training regimen included stretching, calisthenic exercises (25 minutes), cooling down, and warming up (10 min) every patient will perform one to three sets of eight exercise stations (crunches, push-ups, planks, front leg raises, upper back extensions, bicycle crunches, squats, and lunges). With a 10-second break in between stations, each exercise (exercise training) was done for 20 seconds. One set of callisthenic exercises lasted four minutes. The workout intensity was determined by the number of sets, repetitions, and rest interval. With the progression of exercises, week by week, the exercise training's intensity will increase, plus diet advices.

  • OtherCycling Exercises

    the patients will perform moderate-intensity aerobic exercise by (stationary bicycling) three times a week for eight weeks. First, Intensity: the intensity of the exercise was 60-75% of HRmax; it was monitored using a maximum heart-rate monitor and customized using Tanaka's formula. Tanaka method is a formula to estimate a person's maximum heart rate (HRmax) based on their age, using the equation (HR\_{max}=208-(0.7× {age}).Then the participants will do aerobic exercise with a slow speed for 5 min to warm up. After that, they will increase their speed until they reach the target heart rate and maintain it for 20 min. Finally, they will do exercise for 5 min with a slow speed to cool down plus diet advice.

  • Otherdiet advices

    the diet advices include: 1. Integrating a healthier eating habit, having food at the same time every day with regular intervals 2. Never eat too little or too much. 3. Staying properly hydrated 4. Preventing processed, fatty, and spicy food 5. Limiting caffeine, carbonated, and alcoholic drinks 6. Limiting fiber intake to soluble fibers starts with a low dose and builds up gradually. 7. Avoiding insoluble fibers, gas-producing foods like beans, and sweeteners 8. Awareness of dietary intolerance 9. additional advice for increasing physical activity.

06

What researchers measure

Primary outcomes

  1. Interleukin-6 (IL-6)

    Interleukin-6 (IL-6) is measured using methods such as ELISA kits . ELISA kits are widely used, providing reliable, sensitive, and specific measurements.The normal range for Interleukin-6 (IL-6) in healthy adults is typically less than 5 to 7 picograms per milliliter (pg/mL).

    Time frame: up to eight weeks

  2. Irritable Bowel Syndrome Severity

    Irritable Bowel Syndrome Severity Scoring System will be used to assess bowel severity through five clinically significant items over ten days, as follows: frequency ,severity of abdominal pain , degree of abdominal distention or tightness, dissatisfaction with bowel habits, affection of IBS on quality of life. A greater score denotes worse conditions. Each item is rated on a visual analog scale (VAS) from 0 to 100, resulting in an overall score ranging from 0 to 500. Based on the data collected, the IBS-SSS scores are divided into three categories: mild symptoms (from 75 to 174), moderate symptoms (from 175 to 299), and severe symptoms (from 300 to 500) Additionally, a 95-point reduction in total IBS-SSS scores is clinically meaningful, indicating an improvement in symptoms.

    Time frame: up to eight weeks

  3. Frequency of complete spontaneous bowel movements

    Defined as a sense of complete evacuation without laxatives, enemas, or suppositories on the day of the bowel movement or the preceding day. A participant with a weekly complete spontaneous bowel movement frequency rate of three or more and an increase of one or more from baseline is considered a responder. The patients reported the number of their complete spontaneous bowel movements per week at baseline and post-intervention

    Time frame: up to eight weeks

  4. life disability

    Irritable Bowel Syndrome Quality of Life (IBS-QOL) Instrument will be used to assess life disability.A 34-item, patient-reported questionnaire used to assess the health-related quality of life (HRQOL) and the impact of IBS and its treatments on patients' lives. The questionnaire covers eight domains: dysphoria, interference with activity, body image, health worry, food avoidance, social reactions, sexual concerns, and relationships. Responses are given on a 5-point Likert scale, with scores summed and transformed to a 0-100 scale, where higher scores indicate a better quality of life.

    Time frame: up to eight weeks

Secondary outcomes

  1. aerobic capacity

    6 min walk test (6 MWT) : To assess aerobic capacity and endurance, a submaximal exercise test will used. The distance travelled in 6 minutes will used as the outcome to compare changes in performance capacity. The 6 MWT should ideally will be done indoors on a hard-surfaced, straight, and flat corridor that is at least 30 meters long. The patient will instructed to dress and walk comfortably

    Time frame: up to eight weeks

  2. Academic achievement

    Academic achievement will be measured by Academic Achievement Questionnaire (AAQ).The AAQ is a concise tool for measuring three aspects of academic achievement: study performance, handling of study demands, and social adaptation . The first study with a pilot version of AAQ confirmed the three-factor structure using an exploratory factor analysis and specified 9 items for the final version of questionnaire.Higher total = better academic performance

    Time frame: up to eight weeks

  3. sleep disability

    The Pittsburgh Sleep Quality Index (PSQI) uses 19 self-rated questions to yield seven clinical component scores. Each component is scored from 0 (no difficulty) to 3 (severe difficulty). These seven scores are added together to create a global score from 0 to 21, where a total score above 5 indicates significant sleep trouble.

    Time frame: up to eight weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Apr 2027, 8 months later.

Of 305 non-industry interventional studies with no phase under Irritable Bowel Syndrome, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 40. This study's planned 8 months is below that.

Counting every sponsor, half of 357 studies reached it within 19 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 7, 2026
First posted
Aug 12, 2026
StartEst.
Aug 20, 2026
Primary completionEst.
Apr 20, 2027
CompletionEst.
Apr 20, 2027
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07760298
Lead sponsor
Cairo University
Responsible party
Heba Gamal Ali Ali (principle investigator : heba gamal ali ali, Cairo University) — Principal investigator
First posted
Aug 12, 2026
Start date
Aug 20, 2026 (estimated)
Primary completion
Apr 20, 2027 (estimated)
Completion
Apr 20, 2027 (estimated)
Last update
Aug 12, 2026

Study contacts

heba gamal, master
Contact
heba.gamal@fpt.bu.edu.eg
20 12 79657700

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion